Parkinson's disease and issues related to driving

Parkinsonism and Related Disorders

Volumn 15, Issue SUPPL. 3, 2009, Pages

  Uitti, Ryan J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Driving; Motor vehicle safety; Parkinson's disease

Indexed keywords

BROMOCRIPTINE; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DRIVING ABILITY; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; TRAFFIC SAFETY; VISUAL IMPAIRMENT;

ACTIVITIES OF DAILY LIVING; AUTOMOBILE DRIVING; COGNITION DISORDERS; HUMANS; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PSYCHOMOTOR PERFORMANCE; SLEEP DISORDERS; VISION DISORDERS;

EID: 71849093814     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70797-7     Document Type: Article

References (40)

1. Fonda S.J., Wallace R.B., and Herzog A.R. Changes in driving patterns and worsening depressive symptoms among older adults. J Gerontol 56 (2001) S343-S351
2. Marottoli R.A., de Leon C.F.M., Glass T.A., Williams C.S., Cooney Jr. L.M., and Berkman L.F. Consequences of driving cessation: decreased out-of-home activity levels. J Gerontol 55 (2000) S334-S340
3. Meindorfner C., Korner Y., Moller J.C., Stiasny-Kolster K., Oertel W.H., and Kruger H.P. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 20 (2005) 832-842
4. Cordell R., Lee H.C., Granger A., Vieira B., and Lee A.H. Driving assessment in Parkinson's disease - a novel predictor of performance?. Mov Disord 23 (2008) 1217-1222
5. Heikkila V.M., Turkka J., Korpelainen J., Kallanranta T., and Summala H. Decreased driving ability in people with Parkinson's disease. J Neurol Neurosurg Psychiatry 64 (1998) 325-330
6. Zesiewicz T.A., Cimino C.R., Malek A.R., Gardner N., Leaverton P.L., Dunne P.B., et al. Driving safety in Parkinson's disease. Neurology 59 (2002) 1787-1788
7. Dubinsky R. Driving in Parkinson's disease. Neurology 41 (1991) 517-520
8. Madeley P., Hulley J.L., Wildgust H., and Mindham R.H. Parkinson's disease and driving ability. J Neurol Neurosurg Psychiatry 53 (1990) 580-582
9. Stolwyk R.J., Triggs T.J., Charlton J.L., Moss S., Iansek R., and Bradshaw J.L. Effect of a concurrent task on driving performance in people with Parkinson's disease. Mov Disord 21 (2006) 2096-2100
10. Devos H., Vandenberghe W., Nieuwboer A., Tant M., Baten G., and De Weerdt W. Predictors of fitness to drive in people with Parkinson disease. Neurology 69 (2007) 1434-1441
11. Wood J.M., Worringham C., Kerr G., Mallon K., and Silburn P. Quantitative assessment of driving performance in Parkinson's disease. J Neurol Neurosurg Psychiatry 76 (2005) 176-180
12. Amick M.M., Grace J., and Ott B.R. Visual and cognitive predictors of driving safety in Parkinson's disease patients. Arch Clin Neuropsychol 22 (2007) 957-967
13. Uc E.Y., Rizzo M., Anderson S.W., Sparks J.D., Rodnitzky R.L., and Dawson J.D. Impaired navigation in drivers with Parkinson's disease. Brain 130 (2007) 2433-2440
14. Uc E.Y., Rizzo M., Anderson S.W., Sparks J., Rodnitzky R.L., and Dawson J.D. Impaired visual search in drivers with Parkinson's disease. Ann Neurol 60 (2006) 407-413
15. Uc E.Y., and Rizzo M. Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 8 (2008) 377-383
16. Stolwyk R.J., Triggs T.J., Charlton J.L., Iansek R., and Bradshaw J.L. Impact of internal versus external cueing on driving performance in people with Parkinson's disease. Mov Disord 20 (2005) 846-857
17. Worringham C.J., Wood J.M., Kerr G.K., and Silburn P.A. Predictors of driving assessment outcome in Parkinson's disease. Mov Disord 21 (2006) 230-235
18. Uc E. Driving under low contrast visibility conditions in Parkinson's disease. Neurology (2009)
19. Uc E. Increased crash risk in drivers with Parkinson's disease under low visual contrast lighting conditions. Neurology 68 (2007) A208
20. Lings S., and Dupont E. Driving with Parkinson's disease: A controlled laboratory investigation. Acta Neurol Scand 86 (1991) 33-39
21. Johnson E. Omnibus Sleep in America Poll (1998), National Sleep Foundation, Washington, D.C.
22. Sagberg F. Road accidents caused by drivers falling asleep. Accid Anal Prevent 31 (1999) 639-649
23. United States Federal Highway Administration. The driver fatigue and alertness study: a success story of partnerships, data and analysis (1997), Federal Highway Administration, Washington, D.C.
24. Mitler M.M., Miller J.C., Lipsitz J.J., Walsh J.K., and Wylie C.D. The sleep of long-haul truck drivers. N Engl J Med 337 (1997) 755-761
25. Itoi A., and AAA Foundation for Traffic Safety. Can drivers avoid falling asleep at the wheel?: relationship between awareness of sleepiness and ability to predict sleep onset (1993), AAA Foundation for Traffic Safety, Washington, D.C.
26. Frucht S., Rogers J.D., Greene P.E., Gordon M.F., and Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52 (1999) 1908-1910
27. Comella C.L. Sleep disorders in Parkinson's disease: an overview. Mov Disord 22 Suppl 17 (2007) S367-S373
28. Homann C.N., Suppan K., Homann B., Crevenna R., Ivanic G., and Ruzicka E. Driving in Parkinson's disease - a health hazard?. J Neurol 250 (2003) 1439-1446
29. Moller J.C., Stiasny K., Hargutt V., Cassel W., Tietze H., Peter J.H., et al. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord 17 (2002) 474-481
30. Parkinson Study Group. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. JAMA 278 (1997) 125-130
31. Sethi K.D., O'Brien C.F., Hammerstad J.P., Adler C.H., Davis T.L., Taylor R.L., et al. Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group. Arch Neurol 55 (1998) 1211-1216
32. Hobson D.E., Lang A.E., Martin W.R., Razmy A., Rivest J., and Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 287 (2002) 455-463
33. Kulisevsky J. Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels. Brain 119 (1996) 2121-2132
34. Sanjiv C.C., Schulzer M., Mak E., Fleming J., Martin W.R., Brown T., et al. Daytime somnolence in patients with Parkinson's disease. Parkinsonism Relat Disord 7 (2001) 283-286
35. Uitti R.J., and Wszolek Z.K. Dopamine agonists, sleep disorders, and driving in Parkinson's disease. Adv Neurol 91 (2003) 343-349
36. Uc E.Y., Rizzo M., Anderson S.W., Sparks J.D., Rodnitzky R.L., and Dawson J.D. Driving with distraction in Parkinson disease. Neurology 67 (2006) 1774-1780
37. Singh R., Pentland B., Hunter J., and Provan F. Parkinson's disease and driving ability. J Neurol Neurosurg Psychiatry 78 (2007) 363-366
38. Adler G. The older driver with Parkinson's disease. J Gerontol Social Work 34 (2000) 39-49
39. Klimkeit E.I., Bradshaw J.L., Charlton J., Stolwyk R., and Georgiou-Karistianis N. Driving ability in Parkinson's disease: current status of research. Neurosci Biobehav Rev 33 (2009) 223-231
40. Bacon D., Fisher R.S., Morris J.C., Rizzo M., and Spanaki M.V. American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. Neurology 68 (2007) 1174-1177